Cel
The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases are needed. The atherosclerotic changes of the vascular wall are central in the development of cardiovascular complications. The traditional view that atherosclerosis is simply a lipid storage disease has recently been challenged by evidence that inflammation plays a central role in all stages of atherosclerosis. However, molecular mechanisms linking inflammation to atherosclerosis development are not fully understood, and this has severely hampered the advance of diagnostic and therapeutic programs. AtheroRemo aims to identify novel inflammatory mechanisms in vascular remodelling by combining the exploration of human biobanks with animal models and established cellular models. This new knowledge will be used to develop new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular disease. AtheroRemo contains several unique strengths: 1) Outstanding expertise on immunity and inflammation. Our expertise facilitates the breakthroughs in the immuno-inflammatory targeted vascular treatments. 2) Finest European cohorts to search for molecular mechanisms behind atherosclerosis development allowing us to combine underlying genetics with lipidomic profiles in multiple cohorts in order to obtain risk factors and biomarker panel related to inflammatory remodelling. 3) Accelerated target validation with novel liposomal-targeted delivery of nucleic acid-based therapeutics in appropriate animal models. Four SME partners able to exploit the new knowledge support AtheroRemo research. Thus, we expect to translate a number of novel findings into potential clinical applications such as new diagnostic tools (biomarkers) and therapeutics.
Dziedzina nauki
Słowa kluczowe
Zaproszenie do składania wniosków
FP7-HEALTH-2007-A
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
33521 Tampere
Finlandia
Zobacz na mapie
Uczestnicy (19)
Zakończenie uczestnictwa
02044 VTT ESPOO
Zobacz na mapie
17177 Stockholm
Zobacz na mapie
SW7 2AZ LONDON
Zobacz na mapie
20122 Milano
Zobacz na mapie
1211 Geneve
Zobacz na mapie
SW17 0RE London
Zobacz na mapie
02150 Espoo
Zobacz na mapie
89081 Ulm
Zobacz na mapie
115 27 Athina
Zobacz na mapie
5230 Odense M
Zobacz na mapie
5020 Bergen
Zobacz na mapie
02150 Espoo
Zobacz na mapie
25000 BESANCON
Zobacz na mapie
Zakończenie uczestnictwa
06120 HALLE
Zobacz na mapie
69007 Lyon
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
85764 Neuherberg
Zobacz na mapie
79098 FREIBURG
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie